REGENXBIORGNX

那斯達克 · USD
6.88
-0.20
(-2.76%)
盤中 06/17 01:18 (UTC+8)
06/17 01:18 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.22
  • 0.16
  • 0.22
  • 0.24
  • 0.21
  • 0.89
  • 0.21
  • 0.30
  • 0.30
  • 0.06
icon
  • -23.18
  • -29.67
  • 42.72
  • 8.53
  • -12.33
  • 319.59
  • -76.00
  • 39.21
  • 2.03
  • -78.93
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
6,393
30,337
29,733
21,359
89,012
21,214
24,197
22,295
15,622
22,213
營業成本
11,0745,9285,7255,2093,4366,31812,38710,5794,28311,238
營業毛利
-4,681
24,409
24,008
16,150
85,576
14,896
11,810
11,716
11,339
10,975
營業費用
78,68182,04576,41979,42873,44966,264---74,878
研發費用
57,33959,61156,10159,50053,08750,38054,42948,86954,84455,681
推銷及管理費用
21,34222,43420,31819,92820,36220,88419,45918,88418,25719,197
非經常性項目費用
------5,000--2,101-
其他營業費用
----------
營業利益
-83,362
-57,636
-52,411
-63,278
12,127
-51,368
-62,078
-56,037
-63,863
-63,903
其他收入及費用
2,0192,7633,6393,4002,5269,5993,3013,4972,5062,225
利息費用
8,70812,27613,16910,9938,5709,4178204491,9731,363
稅前純益
-90,051
-67,149
-61,941
-70,871
6,083
-51,186
-59,597
-52,989
-63,330
-63,041
所得稅
----------152
稅後純益
-90,051
-67,149
-61,941
-70,871
6,083
-51,186
-59,597
-52,989
-63,330
-62,889
基本每股稅後盈餘(元)
-1.72-1.30-1.20-1.380.12-1.01-1.17-1.05-1.38-
稀釋每股稅後盈餘(元)
-1.72-1.30-1.20-1.380.12-1.00-1.18-1.03-1.38-1.42
基本平均股數(千股)
52428.0051752.0051689.0051483.0051362.0050871.0050800.0050601.0045733.00-
稀釋平均股數(千股)
52428.0051752.0051689.0051483.0051434.0050871.0050800.0050601.0045733.00-
還原基本每股稅後盈餘(元)
-1.72-1.30-1.20-1.380.12-1.01-1.17-1.05-1.38-
還原稀釋每股稅後盈餘(元)
-1.72-1.30-1.20-1.380.12-1.00-1.18-1.03-1.38-1.42
還原基本平均股數(千股)
52,42851,75251,68951,48351,36250,87150,80050,60145,733-
還原稀釋平均股數(千股)
52,42851,75251,68951,48351,43450,87150,80050,60145,733-
EBITDA(千元)
-78,365-52,233-46,709-57,32917,537-38,863-56,132-49,732-57,645-57,585

大家都在看

HOT